- Home
- ATNI vs PRQR Comparison
ATNI vs PRQR Comparison
Compare ATNI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNI
- PRQR
- Stock Information
- Founded
- ATNI 1987
- PRQR 2012
- Country
- ATNI United States
- PRQR Netherlands
- Employees
- ATNI N/A
- PRQR N/A
- Industry
- ATNI Telecommunications Equipment
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- ATNI Telecommunications
- PRQR Health Care
- Exchange
- ATNI Nasdaq
- PRQR Nasdaq
- Market Cap
- ATNI 274.5M
- PRQR 309.5M
- IPO Year
- ATNI 1991
- PRQR 2014
- Fundamental
- Price
- ATNI $17.88
- PRQR $2.56
- Analyst Decision
- ATNI Strong Buy
- PRQR Strong Buy
- Analyst Count
- ATNI 2
- PRQR 6
- Target Price
- ATNI $31.00
- PRQR $8.17
- AVG Volume (30 Days)
- ATNI 63.5K
- PRQR 286.6K
- Earning Date
- ATNI 03-04-2025
- PRQR 03-12-2025
- Dividend Yield
- ATNI 5.37%
- PRQR N/A
- EPS Growth
- ATNI N/A
- PRQR N/A
- EPS
- ATNI N/A
- PRQR N/A
- Revenue
- ATNI $747,493,000.00
- PRQR $20,506,357.00
- Revenue This Year
- ATNI N/A
- PRQR $210.18
- Revenue Next Year
- ATNI $1.20
- PRQR $33.25
- P/E Ratio
- ATNI N/A
- PRQR N/A
- Revenue Growth
- ATNI N/A
- PRQR 306.68
- 52 Week Low
- ATNI $14.74
- PRQR $1.61
- 52 Week High
- ATNI $36.93
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- ATNI 62.46
- PRQR 56.93
- Support Level
- ATNI $17.39
- PRQR $2.47
- Resistance Level
- ATNI $18.43
- PRQR $2.67
- Average True Range (ATR)
- ATNI 0.72
- PRQR 0.18
- MACD
- ATNI 0.27
- PRQR 0.07
- Stochastic Oscillator
- ATNI 84.72
- PRQR 83.58
About ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise US Telecom and International Telecom. The company earns revenue from its telecommunication services.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.